Young Scientists Committed to Finding Treatments for Neurodegenerative Diseases

Andrew Mendiola, PhD named 2020 Berkelhammer Scholar

Unlocking the Drivers of Neuroinflammation in Neurodegenerative Disease

Illustration of amyloid plaques on a nerverticale cell.

MS researcher gets it in gear

Andrew Mendiola, PhD featured in Momentum, the official magazine of the National MS Society

Toxic Cell Atlas Guides New Therapies for Neurodegeneration

Gladstone researchers Jae Kyu Ryu, Katerina Akassoglou, and Andrew Mendiola developed a novel method to profile toxic immune cells in the brain, and used it to identify a therapeutic target for multiple sclerosis.

Tox-seq revealed subtypes of brain immune cells that produce toxic reactive oxygen in a mouse model of MS.

Andrew Mendiola shared his research and his Bike MS experience at the National Multiple Sclerosis Leadership Conference

November 15, 2019

 

Mark Petersen is awarded an NIH/NINDS fellowship entitled, “Fibrinogen-Mediated Mechanisms of Preterm Infant Brain Injury.”

November 10, 2019

$4.5 Million to Study How Neurovascular Dysfunction Contributes to Neurodegeneration in Alzheimer’s Disease

October 31, 2019

Click here to read the full article.

Jorge Palop (left) and Katerina Akassoglou (right) received an NIH grant to study the link between neurovascular dysfunction and cognitive decline in Alzheimer’s disease.